Literature DB >> 28645874

Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state.

Katharine Schwedhelm1, Jerill Thorpe1, Sara A Murray2, Marc Gavin1, Cate Speake3, Carla Greenbaum3, Karen Cerosaletti1, Jane Buckner1, S Alice Long4.   

Abstract

The IL-2/IL-2R pathway is implicated in type 1 diabetes (T1D). While its role in regulatory T cell (Treg) biology is well characterized, mechanisms that influence IL-2 responses in effector T cells (Teff) are less well understood. We compared IL-2 responses in 95 healthy control and 98 T1D subjects. In T1D, low IL-2 responsiveness was most pronounced in memory Teff. Unlike Treg, CD25 expression did not influence the Teff responses. Reduced IL-2 responses in memory Teff were not rescued by resting, remained lower after activation and proliferation, and were absent in type 2 diabetes. Comparing basal IL-2 responses in resting versus activated cells, memory Teff displayed lower, but more sustained, responses to IL-2 overtime. These results suggest that T1D-associated defects in the Teff compartment are due to intrinsic factors related to activation. Evaluation of both Teff and Treg IL-2R signaling defects in T1D subjects may inform selection of therapies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activation; CD4 T cell; IL-2; Signaling; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28645874      PMCID: PMC5564451          DOI: 10.1016/j.clim.2017.06.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  44 in total

Review 1.  Interleukin 2 in the pathogenesis and therapy of type 1 diabetes.

Authors:  Michelle Rosenzwajg; Guillaume Churlaud; Agnès Hartemann; David Klatzmann
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

2.  Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.

Authors:  Denis Comte; Maria P Karampetsou; Katalin Kis-Toth; Nobuya Yoshida; Sean J Bradley; Vasileios C Kyttaris; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2017-04       Impact factor: 10.995

3.  Dual effects of Sprouty1 on TCR signaling depending on the differentiation state of the T cell.

Authors:  Heonsik Choi; Sung-Yup Cho; Ronald H Schwartz; Kyungho Choi
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

Review 4.  Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.

Authors:  R David Leslie; Jerry Palmer; Nanette C Schloot; Ake Lernmark
Journal:  Diabetologia       Date:  2016-01       Impact factor: 10.122

5.  Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Authors:  S Alice Long; Mindi R Walker; Mary Rieck; Eddie James; William W Kwok; Srinath Sanda; Catherine Pihoker; Carla Greenbaum; Gerald T Nepom; Jane H Buckner
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

6.  Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes.

Authors:  Jennie H M Yang; Antony J Cutler; Ricardo C Ferreira; James L Reading; Nicholas J Cooper; Chris Wallace; Pamela Clarke; Deborah J Smyth; Christopher S Boyce; Guo-Jian Gao; John A Todd; Linda S Wicker; Timothy I M Tree
Journal:  Diabetes       Date:  2015-07-29       Impact factor: 9.461

7.  T cell receptor stimulation impairs IL-7 receptor signaling by inducing expression of the microRNA miR-17 to target Janus kinase 1.

Authors:  Gil Katz; Leonid A Pobezinsky; Susanna Jeurling; Miho Shinzawa; Francois Van Laethem; Alfred Singer
Journal:  Sci Signal       Date:  2014-08-26       Impact factor: 8.192

Review 8.  CD4 T cell differentiation in type 1 diabetes.

Authors:  L S K Walker; M von Herrath
Journal:  Clin Exp Immunol       Date:  2015-07-28       Impact factor: 4.330

9.  Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Authors:  S Alice Long; Karen Cerosaletti; Paul L Bollyky; Megan Tatum; Heather Shilling; Sheng Zhang; Zhong-Yin Zhang; Catherine Pihoker; Srinath Sanda; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

10.  Follicular helper T cell signature in type 1 diabetes.

Authors:  Rupert Kenefeck; Chun Jing Wang; Tauseef Kapadi; Lukasz Wardzinski; Kesley Attridge; Louise E Clough; Frank Heuts; Alexandros Kogimtzis; Sapna Patel; Miranda Rosenthal; Masahiro Ono; David M Sansom; Parth Narendran; Lucy S K Walker
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

View more
  6 in total

1.  Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.

Authors:  Tania Habib; S Alice Long; Peter L Samuels; Archana Brahmandam; Megan Tatum; Andrew Funk; Anne M Hocking; Karen Cerosaletti; Michael T Mason; Elizabeth Whalen; David J Rawlings; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

2.  Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Authors:  Manuela Battaglia; Simi Ahmed; Mark S Anderson; Mark A Atkinson; Dorothy Becker; Polly J Bingley; Emanuele Bosi; Todd M Brusko; Linda A DiMeglio; Carmella Evans-Molina; Stephen E Gitelman; Carla J Greenbaum; Peter A Gottlieb; Kevan C Herold; Martin J Hessner; Mikael Knip; Laura Jacobsen; Jeffrey P Krischer; S Alice Long; Markus Lundgren; Eoin F McKinney; Noel G Morgan; Richard A Oram; Tomi Pastinen; Michael C Peters; Alessandra Petrelli; Xiaoning Qian; Maria J Redondo; Bart O Roep; Desmond Schatz; David Skibinski; Mark Peakman
Journal:  Diabetes Care       Date:  2019-11-21       Impact factor: 19.112

3.  Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical Illness.

Authors:  Carmen Mikacenic; Pavan Bhatraju; Cassianne Robinson-Cohen; Susanna Kosamo; Alison E Fohner; Victoria Dmyterko; S Alice Long; Karen Cerosaletti; Carolyn S Calfee; Michael A Matthay; Keith R Walley; James A Russell; Jason D Christie; Nuala J Meyer; David C Christiani; Mark M Wurfel
Journal:  Crit Care Med       Date:  2022-03-01       Impact factor: 7.598

4.  Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Bryan Xu; Matthew Kong; Antonis K Moustakas; George P Bondinas; Annelie Carlsson; Helena Elding-Larsson; Johnny Ludvigsson; Claude Marcus; Martina Persson; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

Review 5.  Genetic basis of defects in immune tolerance underlying the development of autoimmunity.

Authors:  Anne M Hocking; Jane H Buckner
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 6.  Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.

Authors:  Luz Andreone; María Laura Gimeno; Marcelo J Perone
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-17       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.